CLINICAL_TRIALS
trial_result
· 2022-12-16
Clinical Trial Update: Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain [Phase 3]
Summary
Phase 3 trial update for intranasal ketamine as an adjunct to fentanyl for prehospital treatment of acute traumatic pain; trial status ACTIVE_NOT_RECRUITING.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jason McMullan | Conditions: Acute Traumatic Pain | Phase 3 | Status: ACTIVE_NOT_RECRUITING